Zusammenfassung
Ein Einriss des retinalen Pigmentepithels (RIP) bei hochbullösen Pigmentepithelabhebungen (PED) im Rahmen einer Anti-VEGF-Behandlung bei exsudativer altersbedingter Makuladegeneration (eAMD) wurde für die bereits länger verfügbaren Anti-VEGF-Substanzen mehrfach als mögliche Komplikation beschrieben. Seit Ende 2012 steht nun auch Aflibercept als neue Wirksubstanz zur Behandlung der eAMD zur Verfügung. Unsere Kasuistik zeigt den zweiten publizierten Fall eines RIPs nach intravitrealer Aflibercept-Injektion bei PED. Patienten müssen vor der Behandlung explizit über dieses Risiko aufgeklärt werden. Weitere Daten sind zur prozentuellen Risikoeinschätzung erforderlich.
Abstract
Development of tears in the retinal pigment epithelium (RIP) has been described as a possible complication following anti-vascular endothelial growth factor (VEGF) antibody therapy with substances which have been available for years when treating pigment epithelium detachment (PED) in eyes affected by age-related macular degeneration (AMD). Aflibercept has become available for the treatment of exsudative AMD since December 2012. This case report describes a further patient in addition to the only other case published so far who developed RIP after aflibercept treatment for PED. Patients have to be thoroughly informed about this potential side effect before initiation of intravitreal aflibercept injection therapy.
Literatur
Sarraf D, Reddy S, Chiang A et al (2010) A new grading system for retinal pigment epithelial tears. Retina 30:1039–1045
o A (o J) Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands: Die Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration: Therapeutische Strategien. http://www.dog.org
Lommatzsch A (2010) Pigment epithelial detachment in exudative macular degeneration: clinical characteristics and therapeutic options. Ophthalmologe 107:1115–1122
Patel KH, Chow CC, Rathod R et al (2013) Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab. Eye (Lond) 27:663–667 (quiz 668)
Chang LK, Flaxel CJ, Lauer AK, Sarraf D (2007) RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 27:857–863
Chan CK, Meyer CH, Gross JG et al (2007) Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 27:541–551
Sarraf D, Chan C, Rahimy E, Abraham P (2013) Prospective evaluation of the incidence and risk factors for the development of rpe tears after high- and low-dose ranibizumab therapy. Retina 33(8):1551–1557
Saito M, Kano M, Itagaki K et al (2013) Retinal pigment epithelium tear after intravitreal aflibercept injection. Clin Ophthalmol 7:1287–1289
Chan CK, Abraham P, Meyer CH et al (2010) Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina 30:203–211
Spaide RF (2009) Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 147:644–652
Lee SY, Stetson PF, Ruiz-Garcia H et al (2012) Automated characterization of pigment epithelial detachment by optical coherence tomography. Invest Ophthalmol Vis Sci 53:164–170
Bastian N, Fonseca S, Clemens CR et al (2013) Predictive near-infrared SLO signs for tears of the retinal pigment epithelium due to age-related macular degeneration. Klin Monatsbl Augenheilkd 230:270–274
Clemens CR, Bastian N, Alten F et al (2013) Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Acta Ophthalmol [Epub ahead of print]
Coco RM, Sanabria MR, Hernandez AG, Fernández Muñoz M (2012) Retinal pigment epithelium tears in age-related macular degeneration treated with antiangiogenic drugs: a controlled study with long follow-up. Ophthalmologica 228:78–83
Caramoy A, Fauser S, Kirchhof B (2012) Fundus autofluorescence and spectral-domain optical coherence tomography findings suggesting tissue remodelling in retinal pigment epithelium tear. Br J Ophthalmol 96:1211–1216
Clemens CR, Alten F, Baumgart C et al (2013) Quantification of retinal pigment epithelium tear area in age-related macular degeneration. Retina [Epub ahead of print]
Einhaltung ethischer Richtlinien
Interessenkonflikt. T. Bertelmann, W. Sekundo und Y. Wenner geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bertelmann, T., Sekundo, W. & Wenner, Y. Riss des retinalen Pigmentepithels durch intravitreale Aflibercept-Injektion. Ophthalmologe 111, 775–777 (2014). https://doi.org/10.1007/s00347-013-2954-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-013-2954-3
Schlüsselwörter
- Altersbedingte Makuladegeneration
- Anti-VEGF-Therapie
- Pigmentepithelabhebungen
- Komplikation
- Risikoeinschätzung